1 |
Miao D, He B, Jiang Y, Kobayashi T, Soroceanu MA, Zhao J, Su H, Tong X, Amizuka N, Gupta A, Genant HK, Kronenberg HM, Goltzman D, Karaplis AC. Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34. J Clin Invest. 2005;115:2402-2411.
DOI
ScienceOn
|
2 |
Genant HK, Baylink DJ, Gallagher JC. Estrogens in the prevention of osteoporosis in postmenopausal women. Am J Obstet Gynecol. 1989;161:1842-1846.
DOI
ScienceOn
|
3 |
Reid IR. Pharmacotherapy of osteoporosis in postmenopausal women: focus on safety. Expert Opin Drug Saf. 2002;1:93-107.
DOI
|
4 |
Turner CH. Homeostatic control of bone structure: an application of feedback theory. Bone. 1991;12:203-217.
DOI
ScienceOn
|
5 |
Ma CJ, Kim YC, Sung SH. Compounds with neuroprotective activity from the medicinal plant Machilus thunbergii. J Enzyme Inhib Med Chem. 2009;24:1117-1121.
DOI
ScienceOn
|
6 |
Lee MK, Yang H, Ma CJ, Kim YC. Stimulatory activity of lignans from Machilus thunbergii on osteoblast differentiation. Biol Pharm Bull. 2007;30:814-817.
DOI
ScienceOn
|
7 |
Park BY, Min BS, Kwon OK, Oh SR, Ahn KS, Kim TJ, Kim DY, Bae K, Lee HK. Increase of caspase-3 activity by lignans from Machilus thunbergii in HL-60 cells. Biol Pharm Bull. 2004;27:1305-1307.
DOI
ScienceOn
|
8 |
Sowa H, Kaji H, Yamaguchi T, Sugimoto T, Chihara K. Smad3 promotes alkaline phosphatase activity and mineralization of osteoblastic MC3T3-E1 cells. J Bone Miner Res. 2002;17:1190-1199.
DOI
ScienceOn
|
9 |
Ducy P, Schinke T, Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance. Science. 2000;289:1501-1504.
DOI
ScienceOn
|
10 |
Miyazono K, Kamiya Y, Morikawa M. Bone morphogenetic protein receptors and signal transduction. J Biochem. 2010;147:35-51.
DOI
ScienceOn
|
11 |
Chen G, Deng C, Li YP. TGF- and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci. 2012;8:272-288.
DOI
|
12 |
Vukicevic S, Luyten FP, Reddi AH. Stimulation of the expression of osteogenic and chondrogenic phenotypes in vitro by osteogenin. Proc Natl Acad Sci U S A. 1989;86:8793-8797.
DOI
ScienceOn
|
13 |
Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol. 1994;127:1755-1766.
DOI
ScienceOn
|
14 |
Yamaguchi A, Katagiri T, Ikeda T, Wozney JM, Rosen V, Wang EA, Kahn AJ, Suda T, Yoshiki S. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol. 1991;113:681-687.
DOI
ScienceOn
|
15 |
Korchynskyi O, ten Dijke P. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J Biol Chem. 2002;277:4883-4891.
DOI
ScienceOn
|
16 |
Peng Y, Kang Q, Luo Q, Jiang W, Si W, Liu BA, Luu HH, Park JK, Li X, Luo J, Montag AG, Haydon RC, He TC. Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells. J Biol Chem. 2004;279: 32941-32949.
DOI
ScienceOn
|
17 |
Maeda Y, Tsuji K, Nifuji A, Noda M. Inhibitory helix-loop-helix transcription factors Id1/Id3 promote bone formation in vivo. J Cell Biochem. 2004;93:337-344.
DOI
ScienceOn
|
18 |
Moldes M, Lasnier F, Feve B, Pairault J, Djian P. Id3 prevents differentiation of preadipose cells. Mol Cell Biol. 1997;17:1796-1804.
DOI
|
19 |
Lin FH, Chang JB, Brigman BE. Role of mitogen-activated protein kinase in osteoblast differentiation. J Orthop Res. 2011;29:204-210.
DOI
ScienceOn
|
20 |
Itoh S, Itoh F, Goumans MJ, Ten Dijke P. Signaling of transforming growth factor-beta family members through Smad proteins. Eur J Biochem. 2000;267:6954-6967.
DOI
ScienceOn
|